Denmark· DK-28105260213
Dimenhydrinat "Galenica"
A dimenhydrinate product containing dimenhydrinat, registered in Denmark by Galenica SA. The same ATC class is registered in 9 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Dimenhydrinate is registered in 9 of 19 countries.
Countries holding a registration under ATC R06AA11 (dimenhydrinate), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 4 of them publish a price we can compare per daily dose
Dimenhydrinate · ATC R06AA11
9 / 19 countries
- Canada
- Czechiaprice
- Denmark
- Franceprice
- Germany
- Japan
- Norwayprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of dimenhydrinate costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Dimenhydrinate · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- US United States$0.34 (acquisition cost)
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Dimenhydrinat
- Manufacturer
- Galenica SA
- Country
- Denmark (DK)
- ATC code
- R06AA11
- ATC class
- Dimenhydrinate
- Defined daily dose
- 0.3 g, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28105260213
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
85 interactions on record for dimenhydrinate.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dimenhydrinate · interactions on record
85 records
- 3 severe
- 81 moderate
- 1 minor
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium chlorideB05XA01severe
- DicycloverineA03AA07moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under R06AA11
Dimenhydrinate, as other registers publish it.
- United StatesAirmit AceSato Pharmaceutical Co., Ltd.
- CanadaANTI-NAUSEANTVITA HEALTH PRODUCTS INC
- CanadaANTI-NAUSEANT LIQUID GELSVITA HEALTH PRODUCTS INC
- CanadaCONFAB DIMENHYDRINATE 100 MGLABORATOIRES CONFAB INC
- CanadaCONFAB DIMENHYDRINATE 50 MGLABORATOIRES CONFAB INC
- GermanyDimenhydrinat AlAliud Pharma Gmbh
- NorwayDimenhydrinat aluidAliud Pharma
- GermanyDimenhydrinat HamelnHameln Pharma Gmbh
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/39690d53-d5b7-4731-9e38-35bac6e9a779 GET /v1/drugs/39690d53-d5b7-4731-9e38-35bac6e9a779?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "resoribletter, sublinguale",
"source": "dkma",
"strength": "50 mg",
"auth_role": "RMS",
"dk_drugid": "28105260213",
"substance": "Dimenhydrinat",
"auth_procedure": "Decentral procedure",
"in_medicinpriser": false,
"registration_date_serial": "42184"
}See everything about dimenhydrinate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.